nonarteritic anterior ischemic optic neuropathy semaglutide Semaglutide and Non-arteritic Anterior Ischemic Optic Neuropathy: A Systematic Review

Study Links Semaglutide to Increased NAION Risk in Diabetes Patients

20.58

★★★★☆4.8 (126)

Newest Study of Semaglutide and NAION Finds No Increased Risk

28.29

★★★★★4.9 (98)

A new study has raised concerns about the popular diabetes and weight-loss drug Ozempic (semaglutide), linking its use to rare but serious eye conditions such as non-arteritic anterior ischemic optic neuropathy (NAION)

29.02

★★★★★5.0 (157)

The use of semaglutide in patients with diabetes was associated with a significantly increased risk for nonarteritic anterior ischemic optic neuropathy (NAION) compared with those taking drugs for diabetes that belong to

27.57

★★★★★4.7 (84)

Can Semaglutides (Ozempic) Cause Blindness? A recent study hints at a potential link between semaglutide use and an increased risk of a serious eye condition called non-arteritic anterior ischemic optic neuropathy (NAION)

22.09

★★★★★4.9 (203)

Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide : r/Ophthalmology

22.33

★★★★★5.0 (176)

Once-weekly semaglutide doubles the five-year risk of nonarteritic anterior ischemic optic neuropathy in a Danish cohort of 424,152 persons with type 2 diabetes | International Journal of Retina and Vitreous

27.99

★★★★★4.8 (132)